.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Echolight is at the forefront of bone health innovation, backed by extensive clinical research and peer-reviewed studies. Its proprietary REMS (Radiofrequency Echographic Multi-Spectrometry) technology has been validated through rigorous scientific investigations, demonstrating high accuracy and reliability in assessing bone mineral density and bone quality.
Research has shown that REMS overcomes key limitations of traditional bone density testing, providing a radiation-free, highly reproducible, and precise assessment of fracture risk. Echolight’s commitment to evidence-based advancements continues to shape the future of osteoporosis screening and bone health management worldwide.
Radiofrequency Echographic Multi Spectrometry (REMS) in the diagnosis and management of osteoporosis: State of the art
Radiofrequency Echographic Multi Spectrometry (R.E.M.S.): New Frontiers for Ultrasound Use in the Assessment of Bone Status—A Current Picture
New technology REMS for bone evaluation compared to DXA in adult women for the osteoporosis diagnosis: A real-life experience
Radiofrequency Echographic Multi Spectrometry (REMS) for the diagnosis of osteoporosis in a European multicenter clinical context
Fragility Score: A REMS‐based indicator for the prediction of incident fragility fractures at 5 years
Radiofrequency echographic multi spectrometry for the prediction of incident fragility fractures: A 5-year follow-up study
Radiofrequency Echographic Multispectrometry (REMS) can Overcome the Effects of Structural Internal Artifacts and Evaluate Bone Fragility Accurately
Radiofrequency echographic multi‐spectrometry for the in‐vivo
assessment of bone strength: State of the art—outcomes
of an expert consensus meeting organized by the European Society
for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis
and Musculoskeletal Diseases (ESCEO)
Ability of radiofrequency echographic multispectrometry to identify osteoporosis status in elderly women with type 2 diabetes
First assessment of bone mineral density in healthy pregnant women by means of Radiofrequency Echographic Multi Spectrometry (REMS) technology
Literature review of Radiofrequency Echographic Multi-Spectrometry (REMS) in the diagnosis of osteoporosis and bone fragility
Radiofrequency Echographic Multispectrometry (REMS): A New Option in the Assessment Bone Status in Adults with Osteogenesis Imperfecta
Evaluation of the bone mineral density in the Mexican female population using the Radiofrequency Echographic Multi Spectrometry (REMS) technology
Radiofrequency echographic multi-spectrometry-based measurement of bone mineral density in patients with severe motor and intellectual disability: An opportunity for patients with severe scoliosis and
hip dislocation
An observational study of the radiofrequency echographic multi‐spectrometry (REMS)‐based fragility score of the lumbar spine and total fracture risk at 5 years in women
Longitudinal changes of the femoral bone mineral density from first to third trimester of pregnancy: Bone health assessment by means of non‐ionizing REMS technology
Proposed practice parameters for the performance of radiofrequency echographic multispectrometry (REMS) evaluations
Cost-effectiveness of radiofrequency echographic multi-spectrometry for the diagnosis of osteoporosis in the United States
Radiofrequency Echographic Multi Spectrometry (REMS) Technology for Bone Health Status Evaluation in Kidney Transplant Recipients
Cost-minimization analysis to support the HTA of Radiofrequency Echographic Multi Spectrometry (REMS) in the diagnosis of osteoporosis
Could radiofrequency echographic multispectrometry (REMS) overcome the overestimation in BMD by dual-energy X-ray absorptiometry (DXA) at the lumbar spine?
Radiofrequency echographic multi‑spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting
Radiofrequency echographic multispectrometry (REMS): an innovative technique for the assessment of bone status in young women with anorexia nervosa
Reproducibility and Accuracy of the Radiofrequency Echographic Multi-Spectrometry for Femoral Mineral Density Estimation and Discriminative Power of the Femoral Fragility Score in Patients with Primary and Disuse-Related Osteoporosis
Radiofrequency echographic multispectrometry (REMS) Technology for Evaluation of Maternal Bone Mineral Density in Healthy Pregnant Women
Radiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck